🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for HIV Pre-exposure Prophylaxis Use

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention NCT04855773NA4 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Public Health Foundation Enterprises, Inc. · Tests: PrEPmate, Dot Diary Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP NCT05669534Phase 41 site📍 New Haven University of Connecticut · Tests: community-friendly health recovery program, Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs NCT07199335Phase 42 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: APRETUDE (cabotegravir) PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study NCT05769218NA2 sites📍 Boston📍 Boston Boston Medical Center · Tests: CHORUS+, Standard of care Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships NCT07246057NA1 site📍 Philadelphia University of Pennsylvania · Tests: STEP-UP, Philadelphia TelePrEP Program Direct-to-Consumer Model PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI) NCT07683117NA1 site📍 Del Mar EMPOWERX INC · Tests: PEPPI Pharmacies PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence NCT07335289NA2 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Choice of follow up, Follow up via standard clinic Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions NCT06558825NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Integrated Intervention to Promote PrEP Uptake, Standard Treatment Condition Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders NCT06158607NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders, Standard of care treatment Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP NCT07218211Phase 41 site📍 Durham Duke University · Tests: Lenacapavir long-acting BetterInfo on Women's PrEP Choices and Outcomes in Malawi NCT07579754NA1 site📍 Blantyre Johns Hopkins Bloomberg School of Public Health · Tests: Tracing Strategy Predictors of Health Service Utilizations Among Key Population in Washington DC NCT06046079n/a1 site📍 Washington D.C. Us Helping Us, People Into Living, Inc.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy